Vivo Capital »

Palisade Bio shares owned by Vivo Capital

Quarter-by-quarter ownership of Palisade Bio (PALI) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Palisade Bio

Tip: Access up to 7 years of quarterly data

All positions including Palisade Bio held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palisade Bio by Vivo Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.4M 2.3M 2.35

More positions owned by Vivo Capital

Terns Pharmaceuticals Common (TERN)
Cidara Therapeutics Common (CDTX)
Praxis Precision Medicines Common (PRAX)
Cogent Biosciences Common (COGT)
Trevi Therapeutics Common (TRVI)
Avadel Pharmaceuticals Adr (AVDL)
Compass Therapeutics Common (CMPX)
Dyne Therapeutics Common (DYN)
Abivax SA - Sponsored Ads (ABVX)
DBV Technologies SA Sponsored Ads (DBVT)
SAB Biotherapeutics Common (SABS)
Soleno Therapeutics Common (SLNO)
Bright Minds Biosciences Common (DRUG)
Sinovac Biotech SHS
Geron Corp Common (GERN)

View all positions for Vivo Capital

Top funds holding Palisade Bio

Commodore Capital
Point72 Asset Management
Octagon Capital Advisors
Eversept Partners
Franklin Resources
Renaissance Technologies
Vivo Capital
Vanguard Group
ADAR1 Capital Management
Geode Capital Management
Platinum Investment Mangement
Hudson Bay Capital Management
State Street Corporation
Goldman Sachs Group
Jane Street

View all funds holding Palisade Bio